81927-375Level 3
nelarabine (nelarabine)
**Product type:** Human Prescription Drug
**Active ingredient:** NELARABINE
**Strength:** 5 mg/mL
**Dosage form:** Injection
**Route:** Intravenous
**Labeler:** Shorla Oncology Inc.
**Marketing category:** ANDA (ANDA214809)
**Pharmacologic class:** Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
GET
/api/v1/systems/ndc_fda/nodes/81927-375Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.